688639.SH
华恒生物
SSE · Healthcare · Biotechnology · CN
CNY 16.08
−3.65%Next report
Analyst consensus
- Next report date
- Oct 22, 2026
- EPS estimate
- CNY 0.38
- Revenue estimate
- CNY 880.7M
Latest reported
- Last report date
- Aug 24, 2026
- EPS actual
- CNY 0.24
- EPS estimate
- CNY 0.25
- Revenue actual
- CNY 850.8M
- Revenue estimate
- CNY 860.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.1%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 22, 2026